Remifentanil

CHEMBL1005 Phase 4 Approuvé Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
376.4 g/mol
LogP
1.9
Phase
4

An ultra-short-acting opioid analgesic used during surgery and other medical procedures for pain control and sedation, with effects that dissipate within minutes of stopping the infusion. Its rapid onset and offset make it ideal for procedures requiring precise control of pain relief.

Masse moléculaire

376,4000 g/mol

LogP

1,90

TPSA

76,20 Ų

Règle des 5 de Lipinski

Conforme

Aires thérapeutiques

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Structure 2D

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

CCC(=O)N(c1ccccc1)C1(C(=O)OC)CCN(CCC(=O)OC)CC1

InChI

InChI=1S/C20H28N2O5/c1-4-17(23)22(16-8-6-5-7-9-16)20(19(25)27-3)11-14-21(15-12-20)13-10-18(24)26-2/h5-9H,4,10-15H2,1-3H3

Molecular Formula

C20H28N2O5

HBD / HBA

- / 6

Liaisons Rotatives

9

Atomes Lourds

27

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Foire aux questions

An ultra-short-acting opioid analgesic used during surgery and other medical procedures for pain control and sedation, with effects that dissipate within minutes of stopping the infusion. Its rapid onset and offset make it ideal for procedures requiring precise control of pain relief.

Yes, Remifentanil is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1005. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 60815. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

Avertissement médical

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.